COVID and the transport of radiopharmaceuticals

Gilles Degauque, Chairman of Nuclear Medicine Europe’s Transport Expert Working Group, asked our members five general questions about how the coronavirus affected them.

The nuclear medicine sector, like everyone else, has faced and is still facing huge challenges during the coronavirus pandemic. Nuclear Medicine Europe’s Transport Expert Group surveyed its members to find out how it has affected the transport of radioactive material, from shipment and safety to controls and audits.

Share this post